Can somatostatin prevent post‐ERCP pancreatitis? Results of a randomized controlled trial - Concepedia

Concepedia

Publication | Closed Access

Can somatostatin prevent post‐ERCP pancreatitis? Results of a randomized controlled trial

78

Citations

29

References

2004

Year

Dimitrios Arvanitidis, George Anagnostopoulos, Dimitrios Giannopoulos, Athanasios Pantes, ROXANNE AGARITSI, George Margantinis, Stavros Tsiakos, George H. Sakorafas, Panagiotis Kostopoulos

Journal of Gastroenterology and Hepatology

Abstract

Somatostatin is useful in preventing post-ERCP pancreatitis. Further studies must be designed to investigate the cost-effectiveness of the drug and to determine the ideal administration route and dosage.

References

	Year	Citations

Page 1